FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386909911> ?p ?o ?g. }

• W4386909911 endingPage "12" @default.
• W4386909911 startingPage "1" @default.
• W4386909911 abstract "Breast cancer is the second-leading cause of cancer-related death in women and the most often diagnosed malignancy. As the majority of chemotherapeutic medications are associated with recurrence, drug resistance, and side effects, scientists are shifting to beneficial agents for prevention and treatment, such as natural molecules. Myricetin 3-rhamnoside, a natural flavonol glycoside is known for diverse pharmacological activities but fewer reports describe the antiproliferative ability. The study aims to investigate the antiproliferative efficacy and target [hyaluronidase (HYAL) and ornithine decarboxylase (ODC), two poor breast cancer prognostic markers] modulatory potential of myricetin 3-rhamnoside on breast cancer cell lines using cytotoxicity assays and in silico docking, molecular dynamics analysis, cell-free and cell-based test methods. Myricetin 3-rhamnoside significantly retard the growth of MDA-MB-231 cells in SRB (IC50 88.64 ± 7.14 µM) and MTT (56.26 ± 8.50 µM) assay. It suppressed the transition of cells to the S-phase by inducing arrest in the G0/G1 phase with a fold change of 1.10. It shows robust binding interaction with ODC (-7.90 kcal/mol) and HYAL (-9.46 kcal/mol) and inhibits ODC (15.22 ± 2.61 µM) and HYAL (11.92 ± 2.89 µM) activity, but in a cell-based assay, the prominent response was observed against HYAL (21.46 ± 4.03 µM). Besides, it shows a 1.38 fold-down regulation of HYAL and forms a stable complex with HYAL. The binding pocket for myricetin 3-rhamnoside and the simulation pocket during the simulation are identical, indicating that myricetin 3-rhamnoside is actively blocking hyaluronidase. The computational prediction suggests it is a safe molecule. These observations imply that myricetin 3-rhamnoside could be used as a pharmacophore to design and synthesize a novel and safe agent for managing hormone-independent breast cancer.Communicated by Ramaswamy H. Sarma." @default.
• W4386909911 created "2023-09-22" @default.
• W4386909911 creator A5010247793 @default.
• W4386909911 creator A5030784506 @default.
• W4386909911 creator A5072084319 @default.
• W4386909911 creator A5076506630 @default.
• W4386909911 creator A5089239098 @default.
• W4386909911 date "2023-09-21" @default.
• W4386909911 modified "2023-10-16" @default.
• W4386909911 title "Myricetin 3-rhamnoside retards the proliferation of hormone-independent breast cancer cells by targeting hyaluronidase" @default.
• W4386909911 cites W1493318691 @default.
• W4386909911 cites W156191869 @default.
• W4386909911 cites W1579817961 @default.
• W4386909911 cites W1977690808 @default.
• W4386909911 cites W2001487828 @default.
• W4386909911 cites W2037668401 @default.
• W4386909911 cites W2041791898 @default.
• W4386909911 cites W2042197511 @default.
• W4386909911 cites W2044172327 @default.
• W4386909911 cites W2080633639 @default.
• W4386909911 cites W2109689528 @default.
• W4386909911 cites W2114918609 @default.
• W4386909911 cites W2116916471 @default.
• W4386909911 cites W2120343162 @default.
• W4386909911 cites W2124467663 @default.
• W4386909911 cites W2146355999 @default.
• W4386909911 cites W2158332232 @default.
• W4386909911 cites W2168420558 @default.
• W4386909911 cites W2169667899 @default.
• W4386909911 cites W2275032759 @default.
• W4386909911 cites W2320968743 @default.
• W4386909911 cites W2464315990 @default.
• W4386909911 cites W2604766154 @default.
• W4386909911 cites W2793188013 @default.
• W4386909911 cites W2794192359 @default.
• W4386909911 cites W2894011726 @default.
• W4386909911 cites W2935091709 @default.
• W4386909911 cites W2995292489 @default.
• W4386909911 cites W3007269532 @default.
• W4386909911 cites W3035328856 @default.
• W4386909911 cites W3040286719 @default.
• W4386909911 cites W3086078626 @default.
• W4386909911 cites W3112884091 @default.
• W4386909911 cites W3120961315 @default.
• W4386909911 cites W3158585047 @default.
• W4386909911 cites W3163377244 @default.
• W4386909911 cites W3168885611 @default.
• W4386909911 cites W3170386080 @default.
• W4386909911 cites W3198894769 @default.
• W4386909911 cites W4205235716 @default.
• W4386909911 cites W4239133071 @default.
• W4386909911 cites W4282921000 @default.
• W4386909911 cites W4289732140 @default.
• W4386909911 cites W602643467 @default.
• W4386909911 doi "https://doi.org/10.1080/07391102.2023.2256872" @default.
• W4386909911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37732353" @default.
• W4386909911 hasPublicationYear "2023" @default.
• W4386909911 type Work @default.
• W4386909911 citedByCount "0" @default.
• W4386909911 crossrefType "journal-article" @default.
• W4386909911 hasAuthorship W4386909911A5010247793 @default.
• W4386909911 hasAuthorship W4386909911A5030784506 @default.
• W4386909911 hasAuthorship W4386909911A5072084319 @default.
• W4386909911 hasAuthorship W4386909911A5076506630 @default.
• W4386909911 hasAuthorship W4386909911A5089239098 @default.
• W4386909911 hasConcept C109316439 @default.
• W4386909911 hasConcept C121608353 @default.
• W4386909911 hasConcept C126322002 @default.
• W4386909911 hasConcept C181199279 @default.
• W4386909911 hasConcept C185592680 @default.
• W4386909911 hasConcept C202751555 @default.
• W4386909911 hasConcept C2777810353 @default.
• W4386909911 hasConcept C2778004101 @default.
• W4386909911 hasConcept C2778173338 @default.
• W4386909911 hasConcept C2780375986 @default.
• W4386909911 hasConcept C2781263971 @default.
• W4386909911 hasConcept C502942594 @default.
• W4386909911 hasConcept C530470458 @default.
• W4386909911 hasConcept C55493867 @default.
• W4386909911 hasConcept C62112901 @default.
• W4386909911 hasConcept C71924100 @default.
• W4386909911 hasConcept C86803240 @default.
• W4386909911 hasConcept C96232424 @default.
• W4386909911 hasConcept C98274493 @default.
• W4386909911 hasConceptScore W4386909911C109316439 @default.
• W4386909911 hasConceptScore W4386909911C121608353 @default.
• W4386909911 hasConceptScore W4386909911C126322002 @default.
• W4386909911 hasConceptScore W4386909911C181199279 @default.
• W4386909911 hasConceptScore W4386909911C185592680 @default.
• W4386909911 hasConceptScore W4386909911C202751555 @default.
• W4386909911 hasConceptScore W4386909911C2777810353 @default.
• W4386909911 hasConceptScore W4386909911C2778004101 @default.
• W4386909911 hasConceptScore W4386909911C2778173338 @default.
• W4386909911 hasConceptScore W4386909911C2780375986 @default.
• W4386909911 hasConceptScore W4386909911C2781263971 @default.
• W4386909911 hasConceptScore W4386909911C502942594 @default.
• W4386909911 hasConceptScore W4386909911C530470458 @default.
• W4386909911 hasConceptScore W4386909911C55493867 @default.

• next